Literature DB >> 21530329

Smoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosis.

Alicia K Gerke1, Edwin van Beek, Gary W Hunninghake.   

Abstract

RATIONALE/
OBJECTIVES: Smoking has been associated with decreased incidence and prevalence of sarcoidosis, but few studies have evaluated effects of smoking on clinical parameters of the disease. The objectives were to determine the association of smoking with radiographic patterns and to evaluate the associations of these smoking-related radiographic patterns on airflow obstruction in sarcoidosis.
MATERIALS AND METHODS: Clinical data and computed tomography (CT) scans of 124 patients with sarcoidosis were reviewed. CT scans were assessed for lymph nodes, nodules, bronchiectasis, bronchovascular bundle thickening, displaced hilum, fibrosis, ground glass, emphysema, pleural changes, and alveolar opacities. CT patterns were compared between patients with and without a history of smoking. The effect of smoking on the associations between radiographic patterns and airflow obstruction was assessed with multivariable analysis.
RESULTS: Smokers had less frequency of bronchovascular bundle thickening than nonsmokers (11/38 subjects [29%] vs 50/86 subjects [58%], P = .003) and more emphysema (7/38 subjects [18%] vs 1/86 subjects [1%], P = .001). Patients who had bronchovascular bundle thickening were less likely to have ever smoked (11/61 subjects [18%] vs 27/63 subjects [43%], P = .003) or be current smokers (4/61 subjects [7%] vs 15/63 subjects [24%], P = .008). Age (P = .003) and bronchovascular bundle thickening (P = .02) were independent predictors of airflow obstruction. There were no differences in smoking history between patients with airflow obstruction versus those without (10/37 subjects [27%] vs 28/87 subjects [32%], P = .63).
CONCLUSIONS: In patients with sarcoidosis, smoking is associated with decreased frequency of bronchovascular bundle thickening, an important clinical manifestation of the lung disease. Further, bronchovascular bundle thickening and age are the only independent predictors of airflow obstruction, and smoking does not confound these associations.
Copyright © 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530329      PMCID: PMC3115466          DOI: 10.1016/j.acra.2011.02.015

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  24 in total

1.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors.

Authors:  Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2004-09-03       Impact factor: 21.405

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 3.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells.

Authors:  G S Madretsma; G J Donze; A P van Dijk; C J Tak; J H Wilson; F J Zijlstra
Journal:  Immunopharmacology       Date:  1996-10

5.  Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers.

Authors:  Hiroshi Terasaki; Kiminori Fujimoto; Nestor L Müller; Junko Sadohara; Masafumi Uchida; Takeharu Koga; Hisamichi Aizawa; Naofumi Hayabuchi
Journal:  AJR Am J Roentgenol       Date:  2005-08       Impact factor: 3.959

6.  Relationship between presentation of sarcoidosis and T lymphocyte profile. A study in bronchoalveolar lavage fluid.

Authors:  M Drent; H van Velzen-Blad; M Diamant; H C Hoogsteden; J M van den Bosch
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

7.  Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT.

Authors:  D M Hansell; D G Milne; M L Wilsher; A U Wells
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

8.  Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers.

Authors:  E Yamaguchi; A Itoh; K Furuya; H Miyamoto; S Abe; Y Kawakami
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

9.  Cigarette smoking and sarcoidosis.

Authors:  T Peros-Golubicić; S Ljubić
Journal:  Acta Med Croatica       Date:  1995

10.  Smoking does not prevent the onset of respiratory failure in sarcoidosis.

Authors:  K E Ström; A G Eklund
Journal:  Sarcoidosis       Date:  1993-03
View more
  3 in total

1.  Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis.

Authors:  Willane Krell; Julie M Bourbonnais; Rajat Kapoor; Lobelia Samavati
Journal:  Lung       Date:  2012-07-08       Impact factor: 2.584

2.  Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population.

Authors:  Adam C Janot; Dörte Huscher; McCall Walker; Harmonjot K Grewal; Mary Yu; Matthew R Lammi; Lesley Ann Saketkoo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2015-07-22       Impact factor: 0.670

3.  Defining CD4 T helper and T regulatory cell endotypes of progressive and remitting pulmonary sarcoidosis (BRITE): protocol for a US-based, multicentre, longitudinal observational bronchoscopy study.

Authors:  Laura L Koth; Laura D Harmacek; Elizabeth K White; Nicholas Kostandinos Arger; Linda Powers; Brenda R Werner; Roman E Magallon; Pineet Grewal; Briana Q Barkes; Li Li; May Gillespie; Sarah E Collins; Jessica Cardenas; Edward S Chen; Lisa A Maier; Sonia M Leach; Brian P O'Connor; Nabeel Y Hamzeh
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.